Tobramycin Injection, Powder, For Solution
Product Images NDC 70436-110

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 70436-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Image 01)

Chemical structure diagram of tobramycin showing its molecular framework with rings, oxygen, nitrogen, and hydroxyl groups clearly depicted.*

FDA Label Image

Reduced-dosage-nomogram (Image 03)

A reduced dosage nomogram chart for tobramycin showing the relationship between serum creatinine (mg/100 mL) on the x-axis and percent of normal dosage from Table 1 on the y-axis, scaled by creatinine clearance (mL/min/1.73 m²). The graph depicts a diagonal line indicating dose adjustment based on renal function.*

FDA Label Image

Vial Label (Image 04)

Label for Tobramycin for Injection, USP 1.2 grams per pharmacy bulk package by Slate Run Pharmaceuticals, LLC. The label indicates a pharmacy bulk package not for direct infusion, intended for intravenous use. It includes dosing and preparation instructions, storage conditions, and a barcode with the NDC 70436-110.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.